EUDA Health Holdings Limited

NasdaqCM EUDA

EUDA Health Holdings Limited Return on Equity (ROE) for the year ending December 31, 2023

EUDA Health Holdings Limited Return on Equity (ROE) is NA for the year ending December 31, 2023. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

EUDA Health Holdings Limited Return on Equity (ROE) for the year ending December 31, 2022 was 706.83%, a 326.01% change year over year.
EUDA Health Holdings Limited Return on Equity (ROE) for the year ending December 31, 2021 was 165.92%, a 440.76% change year over year.
EUDA Health Holdings Limited Return on Equity (ROE) for the year ending December 31, 2020 was -48.69%.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

NasdaqCM: EUDA

EUDA Health Holdings Limited

CEO	Dr. Wei Wen Chen
IPO Date	Dec. 14, 2021
Location	Singapore
Headquarters	1 Pemimpin Drive
Employees	106
Sector	Healthcare
Industries Telehealth

Description

EUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.

Key trends

Past 5 years